Clinical Trials Browser

Withdrawn × Rectal Neoplasms × pembrolizumab × Clear all

NCT02586610 2017-01-20

Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms